文献速递关节外科

择期全髋关节置换术后30天死亡率负担分析:194,062例患者研究

What Is the 30-Day Mortality Burden After Elective Total Hip Arthroplasty? An Analysis of 194,062 Patients.
PubMed 文献 · J Arthroplasty · 2021-05-24

基于美国外科医师学会国家手术质量改进计划数据库2011-2018年数据,纳入194,062例择期初次全髋关节置换术患者,30天总体死亡率为0.11%。死亡风险在80-89岁、ASA IV级、CCI评分4分及非骨关节炎诊断患者中最高,非骨关节炎队列死亡率高于骨关节炎队列。

要点

  • 择期初次全髋关节置换术30天总体死亡率为0.11%。
  • 80-89岁、ASA IV级、CCI=4分及非骨关节炎诊断患者死亡风险最高。
  • 非骨关节炎诊断在死亡队列中占比显著高于无死亡队列(16.0% vs 7.6%,P < .001)。

核心结论

  • 择期全髋关节置换术后30天死亡风险在80-89岁、ASA IV级、CCI评分4分及非骨关节炎诊断患者中最高。
  • 非骨关节炎队列的总体死亡率高于骨关节炎队列。

研究设计与样本

  • 回顾性队列研究,数据来源于美国外科医师学会国家手术质量改进计划数据库2011-2018年。
  • 共纳入194,062例择期初次全髋关节置换术患者,按30天死亡与否分为死亡组(n=206)和无死亡组(n=193,856)。
  • 记录患者人口学特征、合并症及术前诊断(骨关节炎 vs 非骨关节炎),并按年龄、ASA评分及改良Charlson合并症指数(CCI)分层分析。

主要发现

  • 30天总体死亡率为0.11%。
  • 各年龄组死亡百分比(每1000例归一化):18-29岁0%,30-39岁0%,40-49岁0.049%,50-59岁0.052%,60-69岁0.071%,70-79岁0.133%,80-89岁0.352%。
  • 各ASA评分死亡百分比:ASA I为0%,ASA II为0.035%,ASA III为0.174%,ASA IV为1.008%。
  • 各CCI评分死亡百分比:CCI=0为0.09%,CCI=1为0.23%,CCI=2为0.74%,CCI=3为3.21%,CCI=4为4.76%,CCI≥5为0.57%。
  • 非骨关节炎诊断在死亡队列中占比显著高于无死亡队列(16.0% vs 7.6%;P < .001)。

临床怎么用

  • 对于80-89岁、ASA IV级、CCI评分4分或非骨关节炎诊断的择期全髋关节置换术患者,应充分评估30天死亡风险并加强围手术期管理。

局限性

  • 证据等级为III级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to answer the following questions regarding elective total hip arthroplasty (THA): What is (1) the overall 30-day mortality rate; (2) the mortality rate when stratified by age, comorbidities, and preoperative diagnosis; and (3) the distribution of patient demographics, comorbidities, and preoperative diagnoses between the mortality and mortality-free cohorts? METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was reviewed for all patients undergoing elective primary THA (2011-2018). A total of 194,062 patients were categorized based on the incidence of 30-day mortality (mortality: n = 206 vs mortality-free: n = 193,856). Patient demographics, comorbidities, and preoperative diagnosis (osteoarthritis [OA] vs non-OA) were recorded. Age category, American Society of Anesthesiologists (ASA) score, and modified Charlson Comorbidity Index (CCI) scores were normalized per 1000 and stratified by preoperative diagnosis. RESULTS: The 30-day mortality rate was 0.11%. The percentage of deaths per age group (normalized per 1000) was 0% (18-29 years), 0% (30-39 years), 0.049% (40-49 years), 0.052%(50-59 years), 0.071% (60-69 years), 0.133% (70-79 years), and 0.352% (80-89 years). The percentage of deaths per ASA score was 0% (ASA I), 0.035% (ASA II), 0.174% (ASA III), and 1.008% (ASA IV). The percentage of deaths per CCI score was 0.09% (CCI = 0), 0.23% (CCI = 1), 0.74% (CCI = 2), 3.21% (CCI = 3), 4.76% (CCI = 4), and 0.57% (CCI ≥ 5). Non-OA diagnoses were significantly more frequent in the mortality cohort (16.0% vs 7.6%; P < .001). CONCLUSION: The risk of mortality was highest in patients aged 80-89, patients of ASA class IV, patients with a CCI score of 4, and patients with a non-OA diagnosis. The overall rate of death was higher in the non-OA cohort compared to the OA cohort. LEVEL OF EVIDENCE: III.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. McConaghy KM, Orr MN, Grits D, et al. What Is the 30-Day Mortality Burden After Elective Total Hip Arthroplasty? An Analysis of 194,062 Patients. J Arthroplasty. 2021. PMID: 34116914. doi:10.1016/j.arth.2021.05.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。